Biological effects of G1 phase arrest compound, sesquicillin, in human breast cancer cell lines

Cited 14 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorHa Won Jeong-
dc.contributor.authorHo Jae Lee-
dc.contributor.authorYung Hee Kho-
dc.contributor.authorKwang Hee Son-
dc.contributor.authorMi Young Han-
dc.contributor.authorJong-Seok Lim-
dc.contributor.authorMi Young Lee-
dc.contributor.authorDong Cho Han-
dc.contributor.authorJ H Ha-
dc.contributor.authorByoung-Mog Kwon-
dc.date.accessioned2017-04-19T08:59:12Z-
dc.date.available2017-04-19T08:59:12Z-
dc.date.issued2002-
dc.identifier.issn0968-0896-
dc.identifier.uri10.1016/S0968-0896(02)00225-0ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5892-
dc.description.abstractSesquicillin, isolated from fumgal fermentation broth, strongly induced G1 phase arrest in human breast cancer cells. During G1 phase arrest, the expression level of cyclin D1, cyclin A, and cyclin E was decreased, and the expression of CDK (cyclin-dependent-kinase) inhibitor, protein p21Waf1/Cip1, was increased in a time-dependent manner in a breast cancer cell MCF-7. Interestingly, the G1 phase arrest induced by swsquicillin also occurred independently of the tumor suppressor protein, p53. Sesquicillin inhibits the proliferation of MCF-7 via G1 phase arrest in association with the induction of CDK inhibitor protein, p21Waf1/Cip1, and the reduction of G1 phase related-cyclin proteins.-
dc.publisherElsevier-
dc.titleBiological effects of G1 phase arrest compound, sesquicillin, in human breast cancer cell lines-
dc.title.alternativeBiological effects of G1 phase arrest compound, sesquicillin, in human breast cancer cell lines-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry-
dc.citation.number10-
dc.citation.endPage3134-
dc.citation.startPage3129-
dc.citation.volume10-
dc.contributor.affiliatedAuthorHa Won Jeong-
dc.contributor.affiliatedAuthorHo Jae Lee-
dc.contributor.affiliatedAuthorYung Hee Kho-
dc.contributor.affiliatedAuthorKwang Hee Son-
dc.contributor.affiliatedAuthorMi Young Han-
dc.contributor.affiliatedAuthorJong-Seok Lim-
dc.contributor.affiliatedAuthorMi Young Lee-
dc.contributor.affiliatedAuthorDong Cho Han-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.alternativeName정하원-
dc.contributor.alternativeName이호재-
dc.contributor.alternativeName고영희-
dc.contributor.alternativeName손광희-
dc.contributor.alternativeName한미영-
dc.contributor.alternativeName임종석-
dc.contributor.alternativeName이미영-
dc.contributor.alternativeName한동초-
dc.contributor.alternativeName하지홍-
dc.contributor.alternativeName권병목-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry, vol. 10, no. 10, pp. 3129-3134-
dc.identifier.doi10.1016/S0968-0896(02)00225-0-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Microbiome Convergence Research Center > 1. Journal Articles
Division of A.I. & Biomedical Research > Genomic Medicine Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.